Plain-English translation of NCT06807736 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study is testing how well three different HIV prevention methods work when young people can choose which one suits them best. The three options are a daily oral pill, a vaginal ring inserted monthly, and Cabotegravir, a long-acting injection given every two months. Researchers want to understand which methods people find easiest to stick with and what helps or gets in the way of using them regularly.
HIV prevention methods only work if people actually use them consistently. By letting people choose the method that fits their life best, researchers hope to learn how to make prevention more effective and accessible in real-world health clinics.
You likely qualify if…
You likely don't qualify if…
You would choose one of the three HIV prevention methods to start with, then attend clinic visits over 25 months (about 2 years) to check in with your healthcare provider and provide feedback on how the method is working for you. You can switch between methods, pause, or restart at any time based on what works best for your life. The study tracks whether you're using your chosen method consistently and what makes it easy or hard to stick with.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
South Africa